Vivos Therapeutics Stock (NASDAQ:VVOS), Quotes and News Summary

Q: What sector and industry does Vivos Therapeutics (VVOS) operate in?

Vivos Therapeutics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

Vivos Therapeutics Stock (NASDAQ: VVOS) stock price, news, charts, stock research, profile.

Open	$2.690
Close	$2.720
Volume / Avg.	40.328K / 214.673K
Day Range	2.610 - 2.740
52 Wk Range	2.400 - 48.790
Market Cap	$7.992M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	30
Short Interest	0.91%
Days to Cover	1

Recent News

What's Going On With Vivos Therapeutics Stock?

Vivos Therapeutics shares are trading lower Tuesday. The company filed a prospectus related to the resale of up to 1.73 million shares of common stock by selling shareholders. Vivos said that if the warrants held by the selling stockholder are exercised in full for cash, the company would receive approximately $8.4 million.

Erica Kollmann

Why Doma Holdings Shares Are Trading Higher By Around 34%; Here Are 20 Stocks Moving Premarket

Shares of Doma Holdings Inc. (NYSE: DOMA) rose sharply in today’s pre-market trading after the company entered a merger transaction with TRG to go private at $6.29 per share in cash. Doma Holdings shares jumped 34.1% to $6.09 in pre-market trading

Avi Kapoor

Why U Power Shares Are Trading Lower By Around 54%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of U Power Limited (NASDAQ: UCAR) shares moved lower during Monday’s session after the company announced pricing of registered follow-on offering of 10 million units at a purchase price of $1.20 per unit.

Lisa Levin

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Rating

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

About Vivos Therapeutics Inc

Sector

Health Care

Industry

Health Care Providers & Services

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commerc...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Vivos Therapeutics (VVOS) stock?

You can purchase shares of Vivos Therapeutics (NASDAQ: VVOS) through any online brokerage.

View our list of the best stock brokerages.

Who are Vivos Therapeutics's (VVOS) competitors?

Other companies in Vivos Therapeutics’s space includes: Aesthetic Medical Intl (NASDAQ:AIH), ATI Physical Therapy (NYSE:ATIP), Psychemedics (NASDAQ:PMD), Star Equity Hldgs (NASDAQ:STRR) and American Shared Hospital (AMEX:AMS).

What is the target price for Vivos Therapeutics (VVOS) stock?

The latest price target for Vivos Therapeutics (NASDAQ: VVOS) was reported by Ascendiant Capital on Tuesday, January 17, 2023. The analyst firm set a price target for 2.50 expecting VVOS to fall to within 12 months (a possible -6.72% downside). 0 analyst firms have reported ratings in the last year.

Current Stock Price for Vivos Therapeutics (VVOS)?

The stock price for Vivos Therapeutics (NASDAQ: VVOS) is $2.68 last updated April 19, 2024 at 6:05 PM EDT.

Does Vivos Therapeutics (VVOS) pay a dividend?

There are no upcoming dividends for Vivos Therapeutics.

When is Vivos Therapeutics (NASDAQ:VVOS) reporting earnings?

Vivos Therapeutics’s Q1 earnings are confirmed for Thursday, June 6, 2024.

Is Vivos Therapeutics (VVOS) going to split?

There is no upcoming split for Vivos Therapeutics.

What sector and industry does Vivos Therapeutics (VVOS) operate in?

Vivos Therapeutics is in the Health Care sector and Health Care Providers & Services industry. They are listed on the NASDAQ.

-

-

-

-

-

-

-

-

-

-

-

-

-

-